Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0598853 (
forgetting
)
3,232
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In 1889, in an age preceding the invention of the electrocardiogram, a physician working in the hospitals of Lyon published a remarkable paper on essential paroxysmal tachycardia, of which Bristowe in England and Huppert in Germany had already spoken. The study described 12 cases (including 3 personal cases) of essential paroxysmal tachycardia and 6 secondary tachycardias. They were not all benign, there being 4 deaths out of the 12 cases. From this period on, the term "Bouveret's tachycardia" has been used in France and, with the advances in rhythmology, some have assimilated it to paroxysmal nodal tachycardia. In fact, many forms of paroxysmal essential tachycardia have been recognised at atrial (nodal tachycardia, accessory pathway tachycardia, idiopathic atrial
flutter
and fibrillation) and ventricular levels (benign or ventricular Bouveret's tachycardia). This is an occasion to review the variety of clinical medicine in the accuracy of a rhythmological diagnosis without
forgetting
that the electrocardiogram is essential when the recordings are analysable. The term of Bouveret's tachycardia should be retained but, before electrocardiographic analysis, it englobes all paroxysmal tachycardia occurring in healthy hearts, and not only paroxysmal nodal tachycardia.
...
PMID:[Bouveret's tachycardia]. 1133 62